1059 - Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY - Middendorp, S.; Drent, E.; Bisso, A.; Baardman, S.; Verweij, D.; Salcedo, E.; Coomans, C.; Braem, S.; van de Weg, S.; Meijer, M.; Proost, N.; van de Ven, M.; et al. (Cytotherapy (Oxford, England), 2023)